Morpho (MORPHO) is currently trading at $1.098, reflecting a 24-hour decline of 4.93%. The daily price range has been relatively tight, with a low of $1.074 and a high of $1.16, indicating a lack of volatility and potential consolidation phase.

The trading volume stands at approximately 54.46 million, equating to 9.07% of the market cap, which suggests decent market participation but not enough to drive significant price action. The hourly and daily moving averages are all trending downward, with the 144 SMA indicating a further decline of 7.50%, reinforcing the bearish sentiment in the short term.

Both the 1-hour and 7-day Relative Strength Index (RSI) are at 42, indicating that Morpho is approaching oversold territory but has not yet reached it. The 7-day price change shows a decrease of 6.50%, while the 14-day change indicates a steeper decline of 14.12%, signaling sustained bearish momentum.

Given that the current price is significantly below its all-time high of $4.17 reached in January 2025, the market appears to be under pressure from profit-taking and lack of bullish catalysts. The cumulative technical indicators support a bearish outlook, as all major SMAs are trending lower, and both short-term and medium-term RSI values suggest weakening buying interest.

Considering the current technical indicators, price trends, and overall market sentiment, a Sell rating is warranted. The persistent downward momentum and failure to reclaim critical support levels indicate further downside risk for Morpho in the near term.